Open Innovation in Drug Development: A Case Study of Company L and QPS
碩士 === 國立清華大學 === 國際專業管理碩士班 === 106 === Biotech and pharmaceutical companies are struggling for drug time line and cost cutting. For opening the door of innovation, companies need to come in relationship with other organizations to share with innovative idea and expertise. In this research work, I e...
Main Authors: | Bhor, Kanchan Hanuman, 黎班杰 |
---|---|
Other Authors: | Chang, Yuan-Chieh |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/b7kk45 |
Similar Items
-
The inter-individual variability of quadripulse stimulation (QPS)
by: Enomoto H, et al.
Published: (2015-03-01) -
How do CRO firms enter China: The Case of QPS Taiwan
by: Chi, Chia-Ling, et al.
Published: (2018) -
Inter-individual variability in rTMS, TBS and QPS
by: Yoshikazu Ugawa
Published: (2015-03-01) -
Some evidence supporting the safety of quadripulse stimulation (QPS)
by: Setsu Nakatani-Enomoto, et al.
Published: (2011-10-01) -
Initial psychometric validation of the questionnaire on pain caused by spasticity (QPS)
by: Thorin L. Geister, et al.
Published: (2017-11-01)